T1	Participants 166 228	patients with acute nontraumatic subarachnoid hemorrhage (SAH)
T2	Participants 42 65	subarachnoid hemorrhage
T3	Participants 805 879	42 patients participating in the enoxaparin trial for acute aneurysmal SAH
